Skip to content

Clinical trials

Phase 4 Ocular Hypertension trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Ocular Hypertension Phase: Phase 4 Country / region: United States Clear all

36 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20021
20031
20052
20065
20072
20085
20091
20101
20113
20121
20143
20151
20161
20181
20201
20221
20253
20263

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed27
Recruiting5
Withdrawn2
Active, not recruiting1
Terminated1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Allergan11
Alcon Research6
Pharmaceutical Research Network2
Aerie Pharmaceuticals1
Bausch & Lomb Incorporated1
Bp Consulting, Inc1
Cornerstone Health Care, PA1
East Coast Institute for Research1
Glaukos Corporation1
Indiana University1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Ocular Hypertension36
Glaucoma20
Glaucoma, Open-Angle20
Eye Diseases2
Dry Eye Syndromes1
Exfoliation Syndrome1
Graves Disease1
Graves Ophthalmopathy1
Hyperemia1

Trials

Showing 1 to 25 of 36. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.